Liquidia Corporation (LQDA)
NASDAQ: LQDA · Real-Time Price · USD
89.03
+1.99 (2.29%)
At close: Jul 23, 2026, 4:00 PM EDT
89.00
-0.03 (-0.03%)
After-hours: Jul 23, 2026, 5:22 PM EDT
Liquidia Market Cap
Liquidia has a market cap or net worth of $7.92 billion as of July 23, 2026. Its market cap has increased by 457.93% in one year.
Market Cap
7.92B
Enterprise Value
7.85B
1-Year Change
457.93%
Ranking
Category
Stock Price
$89.03
ChartMarket Cap Chart
Since July 26, 2018, Liquidia's market cap has increased from $167.77M to $7.92B, an increase of 4,619.00%. That is a compound annual growth rate of 61.92%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 23, 2026 | 7.92B | 163.87% |
| Dec 31, 2025 | 3.00B | 201.46% |
| Dec 31, 2024 | 995.33M | 20.97% |
| Dec 29, 2023 | 822.82M | 100.28% |
| Dec 30, 2022 | 410.83M | 62.30% |
| Dec 31, 2021 | 253.13M | 98.01% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Jul 26, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Viatris | 19.95B |
| Neurocrine Biosciences | 17.56B |
| Elanco Animal Health | 12.32B |
| Dr. Reddy's Laboratories | 10.03B |
| Alkermes | 8.78B |
| Hims & Hers Health | 7.73B |
| Lantheus Holdings | 6.72B |
| Amneal Pharmaceuticals | 5.67B |